Related Experiment Videos
[Melatonin, a pertinent prototype for therapeutic innovation]
D Lesieur1, V Leclerc, P Chavatte
1Institut de Chimie Pharmaceutique, Université de Lille II, France.
Therapie
|January 28, 1999
Summary
Melatonin serves as a lead compound for drug design. Researchers modified its structure to understand receptor interactions, leading to potential new drugs and pharmacological tools.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Molecular Modeling
Background:
- Melatonin is a promising lead compound for rational drug design.
- Understanding melatonin's structure-activity relationships is crucial for developing new therapeutics.
Purpose of the Study:
- To rationally modify melatonin's structure to elucidate its role in drug-receptor interactions.
- To develop agonist and antagonist ligands for pharmacological and therapeutic applications.
Main Methods:
- Systematic structural modifications of melatonin.
- Molecular modeling studies to propose a pharmacophore model.
Main Results:
- Identified key structural features influencing melatonin's affinity and activity.
- Developed novel melatonin analogs, including a naphthalenic bioisostere (agomelatin).
Conclusions:
- Melatonin's structure can be rationally modified to yield potent ligands.
- Agomelatin and other developed compounds show therapeutic potential and are advancing in development.